Cargando…

BACE2: A Promising Neuroprotective Candidate for Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common cause of dementia that affects millions of predominantly elderly individuals worldwide. Despite intensive research over several decades, controversies still surround the etiology of AD and the disease remains incurable. Meanwhile, new molecular players of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeap, Yee Jie, Kandiah, Nagaendran, Nizetic, Dean, Lim, Kah-Leong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473127/ https://www.ncbi.nlm.nih.gov/pubmed/36463454 http://dx.doi.org/10.3233/JAD-220867

Ejemplares similares

Getting Lost Behavior in Patients with Mild Alzheimer’s Disease: A Cognitive and Anatomical Model
por: Yatawara, Chathuri, et al.
Publicado: (2017)

The Alzheimer's disease β-secretase enzyme, BACE1
por: Cole, Sarah L, et al.
Publicado: (2007)

From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson’s Disease Modeling and Regenerative Therapy
por: Yeap, Yee Jie, et al.
Publicado: (2023)

Light-Induced Pupillary Responses in Alzheimer's Disease
por: Chougule, Pratik S., et al.
Publicado: (2019)

Associations of AT(N) biomarkers with neuropsychiatric symptoms in preclinical Alzheimer’s disease and cognitively unimpaired individuals
por: Ng, Kok Pin, et al.
Publicado: (2021)

A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
por: Dobrowolska Zakaria, Justyna A, et al.
Publicado: (2018)

Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer's Disease
por: Minocha, Tarun, et al.
Publicado: (2022)

BACE1 inhibitor drugs in clinical trials for Alzheimer’s disease
por: Vassar, Robert
Publicado: (2014)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
por: Maia, Miguel A., et al.
Publicado: (2019)

Current and Future Trends in Biomarkers for the Early Detection of Alzheimer’s Disease in Asia: Expert Opinion
por: Kandiah, Nagaendran, et al.
Publicado: (2022)

Role of BACE1 in Alzheimer’s synaptic function
por: Das, Brati, et al.
Publicado: (2017)

BACE1 Inhibitors for Alzheimer’s Disease: The Past, Present and Any Future?
por: Bazzari, Firas H., et al.
Publicado: (2022)

The β-secretase enzyme BACE1 as a therapeutic target for Alzheimer's disease
por: Vassar, Robert, et al.
Publicado: (2011)

Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs
por: Yan, Riqiang
Publicado: (2016)

BACE1 Translation: At the Crossroads Between Alzheimer’s Disease Neurodegeneration and Memory Consolidation
por: Guix, Francesc X., et al.
Publicado: (2019)

Role of Cognitive Enhancer Therapy in Alzheimer’s Disease with Concomitant Cerebral White Matter Disease: Findings from a Long-Term Naturalistic Study
por: Ng, Kok Pin, et al.
Publicado: (2014)

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
por: Coimbra, Judite R. M., et al.
Publicado: (2018)

Post-Translational Modifications of BACE1 in Alzheimer's Disease
por: Wen, Wen, et al.
Publicado: (2022)

Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease
por: Sun, Zhi-Kun, et al.
Publicado: (2013)

Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice
por: Qiu, Lifeng, et al.
Publicado: (2016)

Frontotemporal Dementia in Southeast Asia: A Comparative Study
por: Tan, Yee-Leng, et al.
Publicado: (2013)

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
por: Koelsch, Gerald
Publicado: (2017)

Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2020)

Marine Natural Products: Promising Candidates in the Modulation of Gut-Brain Axis towards Neuroprotection
por: Fakhri, Sajad, et al.
Publicado: (2021)

Neurotrophic and Neuroprotective Actions of (−)- and (+)-Phenserine, Candidate Drugs for Alzheimer’s Disease
por: Lilja, Anna M., et al.
Publicado: (2013)

Insulin‐like growth factor‐2 is a promising candidate for the treatment and prevention of Alzheimer's disease
por: Fitzgerald, G. S., et al.
Publicado: (2023)

BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012)

BACE1, the Alzheimer’s beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2013)

BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
por: Vassar, Robert
Publicado: (2016)

BACE1: from biomarker to Alzheimer’s disease therapeutical target
por: Cervellati, Carlo, et al.
Publicado: (2021)

Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain
por: Alić, Ivan, et al.
Publicado: (2021)

BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants
por: Timmers, Maarten, et al.
Publicado: (2017)

PS1 Affects the Pathology of Alzheimer’s Disease by Regulating BACE1 Distribution in the ER and BACE1 Maturation in the Golgi Apparatus
por: Li, Nuomin, et al.
Publicado: (2022)

Real-world evaluation of compliance and preference in Alzheimer’s disease treatment
por: Pai, Ming-Chyi, et al.
Publicado: (2015)

Platelet BACE1 levels as a possible biomarker for Alzheimer’s disease
por: Decourt, Boris, et al.
Publicado: (2013)

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
por: Neumann, Ulf, et al.
Publicado: (2018)

BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
por: Sjölander, Annica, et al.
Publicado: (2010)

Chronic Neuroinflammation in Alzheimer's Disease: New Perspectives on Animal Models and Promising Candidate Drugs
por: Millington, Christopher, et al.
Publicado: (2014)

Neuroprotective Effects of Quercetin in Alzheimer’s Disease
por: Khan, Haroon, et al.
Publicado: (2019)

Neuroprotective Herbs for the Management of Alzheimer’s Disease
por: Gregory, Julie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8ot8780bgv68jukc4n28jh4t2